AMERICAN SKIN ASSOCIATION ANNOUNCES 2022 RESEARCH GRANTS FOR SKIN CANCER AND DISEASES

NEW YORK, May 2, 2022 /PRNewswire/ — The American Skin Association has announced the names of the two recipients of the coveted research grant ASA Milstein Research Scholar Awards program. This year Angel ByrdMD, PhD of Howard University College of Medicine and Jennifer GilMD, PhD of University of Texas Southwestern Medical Center were selected to receive the ASA Milstein Research Scholar Award for Melanoma/Non-Melanoma Skin Cancer Grants.

ASA logo (PRNewsfoto/American Skin Association)

ASA logo (PRNewsfoto/American Skin Association)

Another coveted scholarship includes the ASA Daneen & Charles Stiefel Investigative Scientist Award in Melanoma Research. Nicholas GulatiMD, PhD at the Icahn School of Medicine Mount Sinai was selected to receive the award. Over the years, the Stiefel family – longtime supporters of ASA – have contributed generously $600,000 Support grants for melanoma research. This funding aims to support emerging dermatology leaders who are focused on better understanding melanoma in hopes of finding a cure.

In addition, 5 other research grants were announced, made possible by the generosity of individuals, foundations and corporations.

For thirty-five years, ASA and its affiliates have over funded to advance their vital mission of serving the more than 100 million Americans affected by skin diseases 50 million dollars for grants. ASA’s main goal is to improve treatments and continue working towards cures for melanoma, vitiligo, psoriasis, atopic dermatitis and other skin diseases.

“These grants, which support cutting-edge dermatology research, are critical to advancing ASA’s goal of defeating skin cancers such as melanoma. Although the skin is our largest and perhaps our most exposed organ, dermatological research remains one of the most underfunded areas of medicine. ASA’s support will improve the chances of finding the long-sought cure and bringing hope to the millions suffering from devastating skin cancer and other skin diseases,” said the ASA Chairman, Howard P Milstein.

ASA’s fellowship program is governed by its Medical Advisory Committee (MAC), composed of leading scientists and physicians who volunteer their time to oversee the annual fellowship process. Through her leadership, the ASA grant program has supported the work of over 300 researchers, ranging from talented researchers in the early stages of their careers to recognized leaders in the field of dermatology.

“ASA’s Medical Advisory Committee is pleased to announce the 2022 awards. This year’s award winners demonstrate the growing power of research in basic, translational and clinical dermatology. Never before have advances in basic research led to new treatment approaches so quickly. New treatments for vitiligo, psoriasis, atopic dermatitis, melanoma and other types of skin cancer are on the horizon, fueled by significant funding contributions from the ASA,” said ASA President and MAC Co-Chair Dr. David A Norris.

ASA gives major research awards to established researchers and medical students studying melanoma, non-melanoma skin cancer and other skin diseases. Through these grants, ASA has nurtured the early careers of many talented young researchers and made a profound impact on both dermatology research and the clinical management of dermatological disorders. Over the years, ASA-funded researchers have had a profound impact on the understanding of melanoma, improving our understanding of diagnosis, treatment and prognosis. With an exclusive focus on the study of skin diseases, ASA has helped open new frontiers in skin science with results that will transform the way we understand and treat these diseases.

The following are the recipients of the 2022 Investigative Scientist Award, Research Scholar Awards, Research Grants, and Medical Student Scholarships:

2022 ASA Daneen & Charles Stiefel Investigative Scientist Award for Melanoma Research
Nicholas GulatiMD, PhD
Icahn School of Medicine at Mount Sinai
project title: Use of topical diphencyprone to improve checkpoint inhibition efficacy in melanoma patients.

2022 ASA Milstein Research Scholar Award for Melanoma/Non-Melanoma Skin Cancer
Angel ByrdMD, PhD
Howard University medical college
project title: Study of Gene Expression in Mycosis Fungoides in Skin of Color.

2022 ASA Milstein Research Scholar Award for Melanoma/Non-Melanoma Skin Cancer
Jennifer GilMD, PhD
University of Texas Southwestern Medical Center
project title: Characterizing the role of GAPDHS as a metastatic suppressor in human melanoma.

2022 ASA Calder Research Scholar Award for Vitiligo/Pigmental Cell Disorders
Jessica SchiuMD, PhD
University of California Irvine
project title: Investigating the role of keratinocyte-derived signaling networks in vitiligo initiation.

2022 ASA Mulvaney Family Foundation Research Grant in Vitiligo/Pigmental Cell Disorders
Ahmad AlisaMD, FAAD
Medical University of South Carolina
project title: Daily topical therapy with rapamycin (sirolimus) for the treatment of vitiligo.

2022 ASA Castle Biosciences Research Grant in Melanoma
Goran MicevicMD, PhD
Yale School of Medicine
project title: Epigenetic regulation of Slamf6 as a therapeutic strategy in melanoma immunotherapy.

2022 ASA Medical Student Grant Targeting Melanoma and Skin Cancer
MS. Angela Adams
University of Arizona medical school – Phoenix
project title: Novel cutaneous squamous cell carcinoma model to study tumor-specific T cell responses.

2022 ASA Medical Student Grant Targeting Melanoma and Skin Cancer
MS. Victoria Mroz
Icahn School of Medicine at Mount Sinai
Project title: Role of ETS transcription factors in subpopulation heterogeneity of cutaneous squamous cell carcinoma.

ABOUT AMERICAN SKIN ASSOCIATION

A unique collaboration of patients, families, advocates, physicians and scientists, ASA has grown over the past 35 years to become a leading force in efforts to combat melanoma, vitiligo, psoriasis, atopic dermatitis and other skin diseases. The organization was founded to help the now more than 100 million Americans – a third of the US population – who are affected by skin diseases. The organization’s mission remains: to advance research, promote skin health, particularly in children, and raise public awareness of skin conditions. ASA is a 501(c)3 nonprofit organization. Visit www.americanskin.org for more information.

The American Skin Association has received Candid’s Seal of Platinum Transparency.

decision

decision

To download multimedia, view the original content: https://www.prnewswire.com/news-releases/american-skin-association-announces-2022-research-grants-for-skin-cancer-and-diseases-301537748 .html

SOURCE American Skin Association